Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

FDA proposes major shift to COVID vaccine schedule

Under the new proposal, the FDA would conduct an assessment of prevalent strains circulating each year, likely beginning around June, with the aim of new vaccines being ready by September. 

Thumbnail

Why more pulmonary embolism patients should be considered for surgery

The topic was explored at length in a new scientific statement presented at the 59th Annual Meeting of the Society of Thoracic Surgeons.

Thumbnail

Prenatal MRI reveals placental damage caused by COVID

In general, any COVID diagnosis raises risks of fetal harm during pregnancy, but fetuses of women who have been diagnosed with a pre-Omicron variant of the virus are most at risk of developmental impairment, according to new research.

Increased use of CCTA improves CAD outcomes without raising costs

Researchers examined data from nearly 2 million patients, sharing their full findings in JACC: Cardiovascular Imaging.

FDA approves new medication for type 2 diabetes

The newly approved SGLT2 inhibitor, bexagliflozin, is marketed under the name Brenzavvy. It is not recommended for patients with type 1 diabetes. 

Prestigious medical schools hide vital information from radiology residency programs

Would residency directors do better to favor high-achieving students from schools of more modest national status?

An example if an implantable cardioverter defibrillator (ICD and its leads connected to the heart. As the leads or deveice wears out, there are recommendations to remove the leads and put in new ones. Image courtesy of RSNA

Infection, heart failure the most common reasons for early mortality after transvenous lead removal

Early mortality specifically related to complications during the TLR procedure was quite rare. 

A study that analyzed patient outcomes in coronary artery bypass grafting (CABG) in veterans showed outcomes for on-pump and off-pump procedures over 10 years to be similar. Photo by Jim Lennon

CABG bests PCI for multivessel CAD, large new study confirms

"The singular message to the public is that the optimal treatment for multivessel coronary artery disease—to improve not only long-term survival but also lower your risk of complications—is coronary artery bypass surgery," one specialist said in a statement.